SAN FRANCISCO, May 7, 2018 /PRNewswire/ --
The global contrast media agents market size is estimated toreach USD 5.96 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 3.8% during the forecast period. Increasing burden of chronic diseases is augmenting diagnostic imaging procedure
(Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg )
Competitive strategies, such as acquisitions and indication extensions for existent products, adopted by players are expected to trigger the growth of the market. The companies stirring changes in the space is restricted to few in number. Among these, Guerbet, GE Healthcare, and Bayer were the forerunners with top-selling drugs in their respective portfolios and commanding more than 40% share in 2016. Bayer holds a prominent position in the arena owing to its leading MRI agent, Gadavist/Gadovist, a macrocyclic gadolinium agent. Guerbet is giving a stiff competition to its contemporaries since it has joined forces with Mallinckrodt. The acquisition has led to a streamlined portfolio of MRI and x-ray/CT contrast materials, which now hold center position in this space. GE competes with Omnipaque and Visipaque as a part of its suite of offerings, which account for nearly 12.0% market share.
Along with increasing incidence of chronic diseases, rising demand and use of diagnostic imaging modalities is driven by advancements in the underlying technologies. Equipment advancements include innovation such as syringeless injectors, which help in achieving greater accuracy in dose delivery, shorter examination time, and higher patient throughput.
Regionally, North America will continue to dominate the contrast media agents market throughout the forecast period. Presence of well-established healthcare infrastructure, availability of advanced technologies as well as recent launch of new contrast media agents for specific indications are contributing to the growth of the region.
Browse full research report with TOC on "Contrast Media/Contrast Agents Market Analysis, By Agent Type (Iodinated, Barium-based, Gadolinium-based, Microbubble), By Modality (X-ray/CT, MRI, Ultrasound), By Application, And Segment Forecasts, 2018 - 2025" at: https://www.grandviewresearch.com/industry-analysis/contrast-media-contrast-agents-market
Further Key Findings From the Report Suggest:
Browse related reports by Grand View Research:
Grand View Research has segmented the global contrast media agents market on the basis of agent type, modality, application, and region:
Read Our Blog By Grand View Research: https://www.grandviewresearch.com/blogs/healthcare
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: +1-415-349-0058 Toll Free: 1-888-202-9519 Email: firstname.lastname@example.org
SOURCE Grand View Research, Inc.
Subscribe to our Free Newsletters!
Oxidative stress is a form of injury to body tissues due to increase in free radicals. If the ...
Graviola's health benefits range from curing headaches to fighting cancer. Read on to know more ...
Gene therapy is a specialized procedure where genetic material is introduced into the cells of a ...View All